References

Liver disease in pregnancy

10.1016/s0140-6736(09)61495-1 · 2010 · External reference

Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022

10.1111/1471-0528.17206 · 2022 · External reference

Intrahepatic cholestasis of pregnancy

10.3748/wjg.15.2049 · 2009 · External reference

Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis

10.1258/om.2010.090055 · 2010 · External reference

Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution

10.1080/13557859998173 · 1999 · External reference

Perinatal outcomes associated with intrahepatic cholestasis of pregnancy

10.1080/14767058.2017.1332036 · 2018 · External reference

Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy

10.1016/j.ijgo.2013.02.015 · 2013 · External reference

Retrospective analysis of maternal, fetal, and neonatal outcomesof intrahepatic cholestasis of pregnancy at Gazi University

10.3906/sag-1604-76 · 2017 · External reference

Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid

10.1186/s12876-015-0324-0 · 2015 · External reference

Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy

10.1097/meg.0000000000001954 · 2021 · External reference

Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy

10.1016/j.ajog.2015.06.021 · 2015 · External reference

Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels

10.1016/j.ajog.2014.07.026 · 2015 · External reference

Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study

10.1002/hep.26617 · 2014 · External reference

Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study

10.1111/1471-0528.16669 · 2021 · External reference

Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment

10.1016/j.dld.2016.10.006 · 2017 · External reference

Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial

2015 · External reference

Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial

10.1136/bmj.e3799 · 2012 · External reference

Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial

10.1016/s0140-6736(19)31270-x · 2019 · External reference

Endocrinology in pregnancy: Metabolic impact of bile acids in gestation

10.1530/eje-20-1101 · 2021 · External reference

Bile acids in glucose metabolism in health and disease

10.1084/jem.20171965 · 2018 · External reference

Maternal glucose homeostasis is impaired in mouse models of gestational cholestasis

10.1038/s41598-020-67968-6 · 2020 · External reference

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

10.1073/pnas.0506982103 · 2006 · External reference

Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function

10.1002/hep.23849 · 2010 · External reference

Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study

10.1111/1471-0528.12174 · 2013 · External reference

The impact of intrahepatic cholestasis on pregnancy outcomes: a retrospective cohort study

10.1186/s12876-023-02652-3 · 2023 · External reference

A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population

10.1016/j.ejogrb.2017.09.012 · 2017 · External reference

Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes

10.1016/j.ejogrb.2013.12.037 · 2014 · External reference

Association between intrahepatic cholestasis in pregnancy and gestational diabetes mellitus. A retrospective analysis

10.5603/gp.2019.0079 · 2019 · External reference

Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia

10.21037/atm-20-4879 · 2020 · External reference

Intrahepatic cholestasis of pregnancy: Association with glycaemic control in gestational diabetes

10.1111/dme.14574 · 2021 · External reference

Intrahepatic cholestasis of pregnancy can increase the risk of metabolic disorders: A meta-analysis

10.5937/jomb0-33222 · 2022 · External reference

Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis

10.1080/10641955.2020.1758939 · 2020 · External reference

A meta-analysis of the prevalence of gestational diabetes in patients diagnosed with obstetrical cholestasis

10.1016/j.xagr.2021.100013 · 2021 · External reference

Scoping studies: towards a methodological framework

10.1080/1364557032000119616 · 2005 · External reference

Scoping studies: advancing the methodology

10.1186/1748-5908-5-69 · 2010 · External reference

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy

10.2337/dc09-1848 · 2010 · External reference

The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis

10.1186/s13098-019-0406-1 · 2019 · External reference

Rayyan-a web and mobile app for systematic reviews

10.1186/s13643-016-0384-4 · 2016 · External reference

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

10.1186/2046-4053-4-1 · 2015 · External reference